Geography Matters for Infant Gut Microbiome

By Integrative Practitioner Staff 

When it comes to the human microbiome, modern life may be out of sync with ancient biology. “Our bodies are beautifully designed for a world that no longer exists,” says Trevor Lawley, Ph.D., senior group leader of the Host-Microbiota Interactions Lab at the Wellcome Sanger Institute. The trillions of microbes that colonize the gut evolved alongside high-fiber, plant-based diets, which are now dramatically altered by processed foods, antibiotics, formula feeding, and rising Caesarean-section rates. 

Now, a sweeping global atlas of infant gut bacteria published in Cell (DOI: 10.1016/j.cell.2026.01.007) is challenging long-standing assumptions in the probiotic industry. The study maps the global diversity of two keystone infant microbes—Bifidobacterium longum and the rapidly disappearing Bifidobacterium infantis—and lays the groundwork for geographically tailored probiotics designed to better reflect local diets and evolutionary history. 

At the center of the findings is B. infantis. Once common worldwide, the bacterium is now largely absent in infants in Western Europe and North America but remains prevalent in parts of Africa and South Asia. Commercial infant probiotics, Lawley notes, are strikingly uniform: most derive from a strain isolated from a single German infant in 1940. Despite being marketed under different names, they are essentially clonal. 

The new atlas reveals that this one-size-fits-all approach misses enormous genetic diversity. Researchers identified 36 clades of B. infantis grouped broadly by region—Europe, North America, West Africa, East Africa, and Asia—each reflecting adaptation to local diets and breast milk composition. “We can look at the genomes of these bugs from each region and predict what the local diet is,” Lawley says. 

Functionally, B. infantis is uniquely equipped to metabolize components of breast milk that other microbes cannot. Among its conserved gene clusters are those that break down urea, potentially recycling nitrogen into amino acids to support infant muscle growth. It also establishes B vitamins, which are critical for infant neural development, and participates in c processing—essential for neuronal membranes.  

The disappearance of this microbe in Western infants may have long-term consequences. Babies delivered by C-section—now more than 25% of births in the U.S. and U.K., and about 60% in Colombia—are more likely to acquire hospital-associated microbes such as Enterococcus faecalis rather than beneficial bifidobacteria. A 2024 study in Nature Microbiology (DOI: 10.1038/s41564-024-01804-9) found that early microbial “priority effects” help determine which ecosystem takes hold in the infant’s gut, shaping immune and metabolic development. 

The atlas also underscores geopolitical challenges. More than 100 countries have ratified the Nagoya Protocol governing fair access and benefit-sharing of genetic resources, which has set up “hidden invisible barriers” to synchronization. The overarching message is both scientific and societal: geography, diet, and early-life microbial exposures matter. If modern lifestyles have disrupted an ancient partnership between mothers, babies, and microbes, rebuilding it may require a fundamental reorganization of probiotics. 

To read the full story written by Deborah Borfitz, visit Bio-IT World.